Oncology & Cancer

Opting to track, not treat, early prostate cancer

(AP) -- John Shoemaker visited six doctors in his quest to find the best treatment for his early stage prostate cancer - and only the last one offered what made the most sense to the California man: Keep a close watch on ...

Oncology & Cancer

Mark of malignancy identified in prostate cancer

Prostate cancer is the second deadliest cancer in men in the U.S. It kills more than 26,000 men in the country every year. But, as in the case of breast cancer, one prostate cancer will progress rapidly while another tumor ...

Oncology & Cancer

New concept drug hunts down late-stage prostate cancer

A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumor cells, is well tolerated by patients and keeps them ...

Oncology & Cancer

Landmark study describes prostate cancer metastasis switch

Prostate cancer doesn't kill in the prostate – it's only once the disease travels to bone, lung, liver, etc. that it turns fatal. Previous studies have shown that loss of the protein E-Cadherin is essential for this metastasis. ...

page 18 from 40